Dextran sulfate microparticles encapsulating isoniazid and/or rifabutin as carriers for pulmonary tuberculosis therapy
Tuberculosis (TB) is an active deadly pathology with high prevalence worldwide, occurring upon infection with Mycobacterium tuberculosis (MTB). Although conventional oral therapy is effective, it is associated with severe side-effects. The need to overcome these effects, which often lead to patient...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | conferenceObject |
| Language: | eng |
| Published: |
2019
|
| Online Access: | http://hdl.handle.net/10400.1/13052 |
| Country: | Portugal |
| Oai: | oai:sapientia.ualg.pt:10400.1/13052 |